Orbimed Advisors - GEMINI THERAPEUTICS INC ownership

GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 52 filers reported holding GEMINI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$9,555,000
-3.0%
5,826,223
-0.0%
0.18%
-0.6%
Q2 2022$9,846,000
+21.6%
5,826,2240.0%0.18%
+35.9%
Q1 2022$8,098,000
-52.2%
5,826,2240.0%0.13%
-39.9%
Q4 2021$16,954,000
-28.0%
5,826,2240.0%0.22%
-15.8%
Q3 2021$23,538,000
-37.6%
5,826,2240.0%0.26%
-32.0%
Q2 2021$37,696,000
-52.3%
5,826,2240.0%0.38%
-48.4%
Q1 2021$78,945,0005,826,2240.74%
Other shareholders

There were no reported owners of GEMINI THERAPEUTICS INC in Q2 2022.

NameSharesValueWeighting ↓
View complete list of GEMINI THERAPEUTICS INC shareholders